TOP TIERMARKET NEWSWIRE
News & sentiment

INTELLIA THERAPEUTIC (NTLA) — News & AI sentiment

INTELLIA THERAPEUTIC (NTLA) news roundup. 16 stories in the past week, 29 over 30 days. Average 30-day sentiment is 58.6/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 4 sales totalling $507K — net selling of $507K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
16
avg sentiment 60/100
30d stories
29
avg sentiment 58.6/100
Insider net (90d)
$507K
0 buys · 4 sells
Congress (90d)
0
0 buys · 0 sells

NTLA news in the last 24 hours, 7 days, 30 days and 90 days

How much NTLA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowNTLA storiesAvg AI sentimentRead
Last 24 hours0no coverage
Last 7 days1660/100NTLA headlines →
Last 30 days2958.6/100NTLA headlines →
Last 90 days5358.3/100NTLA headlines →

Latest stories on NTLA

3d ago
3d ago
4d ago
H.C. Wainwright reiterates Intellia stock rating on FDA review progress
Investing.com Analyst Ratings56 · neutralanalyst
4d ago
Citizens reiterates Intellia stock rating on FDA priority review
Investing.com Analyst Ratings56 · neutralanalyst
4d ago
5d ago
5d ago
Why is Intellia Therapeutics stock rallying today?
Investing.com Markets50 · neutralgeneral
5d ago
5d ago
5d ago
Intellia Therapeutics stock jumps on FDA priority review
Investing.com Markets67 · bullishproduct/pr
5d ago
5d ago
5d ago
5d ago
Citizens reiterates Intellia stock rating on HAE opportunity potential
Investing.com Analyst Ratings56 · neutralanalyst
5d ago
Sep 4
Sep 4
Sep 4
Sep 4
Sep 4
Intellia Therapeutics secures $400M loan facility
Seeking Alpha46 · neutralgeneral
Sep 4
Sep 4
Sep 4
Sep 4
Sep 4
Open NTLA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →